Conversely, induced transcript expression of the hepatic lipid transporter low density lipoprotein receptors (LDLR) was observed that leads to an increased intracellular lipid load, while, fatty acid binding protein (FABP7) was repressed indicating an alternative role in NAFLD. The gene discussed is LDLR; the disease is metabolic dysfunction-associated steatotic liver disease.